GLP Watchdog

Good Life Meds vs Noom

Neither Good Life Meds nor Noom has an FDA warning letter on record. On compounded semaglutide injection, Noom costs $240 less a year at standing rates: $179 a month against $199 a month at Good Life Meds.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Good Life Meds / Noom

Good Life Meds logo

Good Life Meds

7.6/10

Noom logo

Noom

5.8/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
43 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Good Life Meds
Visit Noom

Neither Good Life Meds nor Noom pays us. Links to them earn nothing. Scores: Good Life Meds 7.6, Noom 5.8. How we are paid

What the record shows

  1. 01

    Neither Good Life Meds nor Noom has an FDA warning letter on record.

  2. 02

    Good Life Meds names two pharmacies. Noom names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Noom costs $240 less a year at standing rates: $179 a month against $199 a month at Good Life Meds.

  4. 04

    Only Noom lists a price for brand-name tirzepatide pen.

  5. 05

    Good Life Meds lists 43 states. Noom publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Good Life Meds

Noom

Compounded semaglutide injection

$199/mo

$2,388 a year

$179/moLower

$2,148 a year

Brand-name tirzepatide pen
Not sold or not priced

$349/mo

$4,188 a year

Price includes
Medication, clinician visits, shipping
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
Auto-renewing subscription at the chosen interval
Not stated
Refunds
All prescription sales final; refunds generally not offered
Refunds only before a prescription is written; renewal charges are not refunded
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Good Life Meds: October 17, 2026. Noom: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Good Life Meds

7.6/10
  • Names its compounding pharmacy
Visit Good Life Meds

The case for Noom

5.8/10
  • $240 a year less on compounded semaglutide injection
  • Sells brand-name tirzepatide pen, which Good Life Meds does not price
  • Names no compounding pharmacy
  • Publishes no state list
Visit Noom

Scores

Good Life Meds 7.6 · Noom 5.8 out of 10. Six weighted parts.

Value25%

5.0A
vs
B
0.9

Effectiveness25%

9.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
6.5

Accessibility10%

8.9A
vs
B
5.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Good Life Meds vs Noom: questions

Neither Good Life Meds nor Noom has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Good Life Meds names two pharmacies. Noom names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Noom, by $240 a year at standing rates. Good Life Meds: $199 a month, about $2,388 a year. Noom: $179 a month, about $2,148 a year.
Good Life Meds states you can cancel at any time; refunds: all prescription sales final; refunds generally not offered. Noom states you can cancel at any time; refunds: refunds only before a prescription is written; renewal charges are not refunded.
Neither Good Life Meds nor Noom pays us. Links to them earn nothing. Scores: Good Life Meds 7.6, Noom 5.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks